Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer to remain aggressive on obesity market after setback
06:03pm, Monday, 08'th Jan 2024
Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Execu
2024's Top 7 Rebound Picks: Contrarian Stocks in Rising Sectors
02:02pm, Monday, 08'th Jan 2024
2023 was an unexpectedly strong year for the stock market. The emergence of generative AI created what might have otherwise been a disastrous year.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:31am, Monday, 08'th Jan 2024
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 low-priced gene therapy stocks to speculate on
08:26am, Monday, 08'th Jan 2024
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences.
Top 2 Stocks For 2024 To Buy Before The Market Realizes It
08:30am, Sunday, 07'th Jan 2024
The technology sector is experiencing a harsh dose of reality as late FOMO buyers suffered a pullback after rushing before the year ended. Optimism among small speculators reached frothy levels in Dec
2024's Market Movers: Top 10 Stocks Set to Dominate the New Year
10:20am, Saturday, 06'th Jan 2024
A new year brings new questions for investors looking to find the top stocks for 2024. Will the long-forecast recession be confirmed?
5 Relatively Secure And Cheap Dividend Stocks To Invest In - January 2024
09:30am, Saturday, 06'th Jan 2024
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
7 Rock-Solid Healthcare Dividend Stocks to Buy in January
09:10am, Saturday, 06'th Jan 2024
The Pharmaceutical segment offers human health pharmaceutical products in: Oncology, Hospital acute care Immunology Neuroscience Virology Cardiovascular and diabetes Vaccine products, such as preventi
3 Magnificent High-Yield Dividend Stocks to Buy in 2024
07:50am, Saturday, 06'th Jan 2024
AbbVie is a Dividend King that should soon return to growth. Bristol Myers Squibb boasts an impressive streak of dividend hikes and a promising pipeline.
Pfizer: 50% Down From The Highs, Generous Dividend, And Robust Balance Sheet
06:54am, Saturday, 06'th Jan 2024
Big pharma is one of the laggards and now rotational targets headed into 2024. Pfizer is one of the worst performers of the group, but also one of the oldest and most mature of the peer group. If the
Is the January Effect reliable indicator for yearly performance?
10:21am, Thursday, 04'th Jan 2024
The S&P 500 and other major indexes are getting off to a slow start to kick off the new year. Some of 2023's leading stocks including Tesla Inc. NASDAQ: TSLA, Norwegian Cruise Line Holdings Ltd.
2 Biotech Stocks For Your January 2024 Watchlist
09:41am, Thursday, 04'th Jan 2024
Biotech stocks to watch in the stock market today.
Dividend Harvesting Portfolio Week 148: $14,800 Allocated, $1,312.61 In Projected Dividends
09:00am, Thursday, 04'th Jan 2024
The Dividend Harvesting Portfolio finished 2023 with an account balance of $15,931.25 and is projected to generate $1,312.61 of forward dividend income.
Pfizer shares downgraded as patent expirations loom
08:43am, Thursday, 04'th Jan 2024
Pfizer Inc. shares PFE, were downgraded to market perform from outperform at TD Cowen on Thursday, as analysts see upcoming patent expirations and shaky confidence in the drugmaker's management cloudi
Pfizer (PFE) Flat As Market Sinks: What You Should Know
06:47pm, Wednesday, 03'rd Jan 2024
Pfizer (PFE) closed the most recent trading day at $29.73, making no change from the previous trading session.
